Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time

25Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Introduction: Diabetes, obesity, and metabolic syndrome are highly prevalent in patients with severe mental illness. Psychotropic polypharmacy is becoming increasingly prevalent within the UK. We determined the change in the number of psychotropic medications prescribed over time and trends in weight and fasting blood glucose. Methods: One hundred ninety-five individuals with schizophrenia and psychosis on the Severe Mental Illness Register in Cheshire, UK, were followed up between 2004 and 2012. Individuals were identified through a semianonymised search of general practitioner registers. Results: The total number of different medications prescribed increased from 140 in 2004 to 226 in 2012 with the mean number of medication groups per patient increasing from 0.71 to 1.15 (p

Cite

CITATION STYLE

APA

Heald, A., Livingston, M., Yung, A., & De Hert, M. A. (2017). Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time. Human Psychopharmacology, 32(2). https://doi.org/10.1002/hup.2579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free